THB 5.85
(N/A%)
Year | EBITDA | EBITDA Growth |
---|---|---|
2023 | 120.87 Million THB | -70.47% |
2022 | 406.2 Million THB | -7.77% |
2021 | 435.39 Million THB | 233.49% |
2020 | 133.09 Million THB | 18.75% |
2019 | 112.08 Million THB | 46.37% |
2018 | 76.57 Million THB | -2.78% |
2017 | 84.28 Million THB | -14.4% |
2016 | 92.01 Million THB | 0.0% |
Year | EBITDA | EBITDA Growth |
---|---|---|
2024 Q1 | -4.52 Million THB | -105.9% |
2024 Q2 | 15.34 Million THB | 714.58% |
2023 Q3 | 23.63 Million THB | -43.46% |
2023 Q1 | 17.87 Million THB | 18.57% |
2023 FY | - THB | -70.47% |
2023 Q4 | 42.34 Million THB | 79.15% |
2023 Q2 | 41.8 Million THB | 133.83% |
2022 Q1 | 179.55 Million THB | 128.53% |
2022 Q4 | 15.07 Million THB | -84.21% |
2022 FY | - THB | -7.77% |
2022 Q3 | 95.49 Million THB | -19.92% |
2022 Q2 | 119.25 Million THB | -33.58% |
2021 Q2 | 90.64 Million THB | 292.83% |
2021 Q4 | 78.56 Million THB | -68.77% |
2021 Q1 | 23.07 Million THB | -56.08% |
2021 Q3 | 251.58 Million THB | 177.54% |
2021 FY | - THB | 233.49% |
2020 Q2 | 44.56 Million THB | 279.17% |
2020 FY | - THB | 18.75% |
2020 Q4 | 52.53 Million THB | 116.73% |
2020 Q3 | 24.24 Million THB | -45.61% |
2020 Q1 | 11.75 Million THB | -37.91% |
2019 Q3 | 32.43 Million THB | 0.0% |
2019 FY | - THB | 46.37% |
2019 Q4 | 18.92 Million THB | -41.63% |
2018 FY | - THB | -2.78% |
2017 FY | - THB | -14.4% |
2016 FY | - THB | 0.0% |
Name | EBITDA | EBITDA Difference |
---|---|---|
E for L Aim Public Company Limited | 83.32 Million THB | -45.069% |
Healthlead Public Company Limited | 159.04 Million THB | 24.0% |
Techno Medical Public Company Limited | 40.42 Million THB | -199.003% |
Winnergy Medical Public Company Limited | 89.19 Million THB | -35.516% |